Simmons Jeffrey N reported grant involving 105.5612 derivative units of Elanco Animal Health Inc at $26.78 for $2.83k on Nov 13, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
PRESIDENT, CEO AND DIRECTOR
PRESIDENT, CEO AND DIRECTOR
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$2,826.93Shares × reported price
Shares traded
105.5612Deferred Stock Units
Price per share
$26.78Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
25,847.4735Direct
Trade date
Nov 13, 2026Grant
Filed
Nov 17, 2026, 4:59 PM ET4-day reporting delay
Accession
0001479079-26-000051Code A · Transaction 404008
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

ELAN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ELAN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −13%1w ago −0.4%1d ago +2.5%
Returns since7d30d90d180d1y

Footnotes in full

F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.